Image 1 of 1
Tesamorelin 10 mg – GHRH-Receptor Research | Pituitary and GH–IGF-1 Signalling | Premium Research Compound
A premium research compound supplied in a convenient 10 mg vial.
Tesamorelin is a stabilised synthetic analogue of human growth-hormone-releasing hormone. It is investigated in laboratory and clinical research involving GHRH-receptor activity, pituitary signalling, growth-hormone secretion, the GH–IGF-1 axis, lipid metabolism, and body-composition pathways.
What’s Included
1x Tesamorelin 10 mg vial
Over 99% Purity
Premium-quality research compound
Shipped from the Gold Coast, Queensland
Australia Post Express Post
Why Choose Tesamorelin 10 mg?
Tesamorelin is a modified 44-amino-acid analogue corresponding to the full sequence of human growth-hormone-releasing hormone.
Researchers investigate Tesamorelin in relation to:
GHRH-receptor activation
Pituitary somatotroph-cell activity
Growth-hormone secretion pathways
GH–IGF-1 axis signalling
Pulsatile endocrine activity
Lipid-metabolism pathways
Adipose-tissue signalling
Body-composition research
Its stabilised GHRH-based structure makes Tesamorelin an important compound for specialised endocrine, pituitary, metabolic, and receptor-signalling research.
Tesamorelin Research
Tesamorelin is commonly investigated in laboratory and clinical research relating to:
Growth-hormone-releasing hormone activity
GHRH-receptor binding and activation
Pituitary-cell signalling
Growth-hormone secretory responses
IGF-1-associated pathways
Somatotropic-axis activity
Visceral-adipose-tissue metabolism
Lipolytic signalling
Triglyceride-metabolism pathways
Glucose-regulation mechanisms
Liver-fat research
Body-composition changes
Research continues into how Tesamorelin influences pituitary signalling, endogenous growth-hormone release, IGF-1-associated activity, lipid metabolism, and adipose-tissue pathways.
Growth-Hormone-Releasing Hormone Analogue Research
Tesamorelin is a synthetic analogue of human GHRH (1–44) with an N-terminal modification designed to improve resistance to enzymatic degradation.
It is composed of the following 44-amino-acid sequence:
Tyr-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-Gln-Gln-Gly-Glu-Ser-Asn-Gln-Glu-Arg-Gly-Ala-Arg-Ala-Arg-Leu
Researchers investigate this specialised peptide for its potential to:
Bind to growth-hormone-releasing hormone receptors
Activate receptor-mediated pituitary signalling
Influence endogenous growth-hormone secretion
Affect GH–IGF-1 axis activity
Support research into lipid-metabolism pathways
Assist investigation of adipose-tissue signalling
Influence body-composition markers under controlled conditions
Available evidence includes laboratory and clinical research involving regulated pharmaceutical preparations. Results from those preparations cannot be assumed to apply to an independently supplied research compound.
Premium Research Compound. One Easy Order.
OZZ Peptides Tesamorelin 10 mg provides researchers with a convenient option for investigating GHRH-receptor activity, pituitary signalling, GH–IGF-1 pathways, lipid metabolism, and adipose-tissue biology.
Securely packed and shipped directly from the Gold Coast using Australia Post Express Post.
Product Highlights
🧬 GHRH-Analogue Research
A stabilised 44-amino-acid analogue of human growth-hormone-releasing hormone.
🔬 Pituitary-Signalling Research
Investigated for its interaction with GHRH receptors on pituitary somatotroph cells.
📈 GH–IGF-1 Axis Research
Studied in relation to endogenous growth-hormone secretion and IGF-1-associated signalling.
🧫 Adipose-Tissue Research
Used in controlled studies examining visceral-adipose-tissue and body-composition pathways.
⚡ Lipid-Metabolism Research
Investigated in relation to lipolysis, triglyceride metabolism, and cellular-energy regulation.
🔄 Endocrine-Pathway Research
Studied for its role in receptor-mediated and pulsatile endocrine signalling.
💎 Over 99% Purity
Premium-quality research compound.
📦 Fast Australian Delivery
Sent using Australia Post Express Post.
🌴 Gold Coast Based
Packed and shipped by the OZZ Peptides team in Queensland.
What You’ll Receive
1x Tesamorelin 10 mg vial
Securely packed for delivery
Australia Post Express Post
Storage
Store according to the storage information supplied with the product.
Before reconstitution, keep the vial in a cool, dry environment away from direct sunlight. After reconstitution, appropriate refrigerated storage may be required according to the supplier’s specifications and applicable laboratory protocol.
Important Information
Products supplied by OZZ Peptides are intended for laboratory research purposes only and are not intended for human consumption, injection, growth-hormone enhancement, fat loss, weight management, body-composition modification, performance enhancement, diagnosis, treatment, cure, or prevention of any disease.
This Tesamorelin research preparation has not been evaluated by the Australian Therapeutic Goods Administration for safety, quality, or effectiveness and is not supplied as an approved medicine.
Athlete warning: Growth-hormone-releasing factors and their analogues are prohibited under the World Anti-Doping Agency Prohibited List. Competitive athletes should not use or handle this product outside properly authorised research settings.
A premium research compound supplied in a convenient 10 mg vial.
Tesamorelin is a stabilised synthetic analogue of human growth-hormone-releasing hormone. It is investigated in laboratory and clinical research involving GHRH-receptor activity, pituitary signalling, growth-hormone secretion, the GH–IGF-1 axis, lipid metabolism, and body-composition pathways.
What’s Included
1x Tesamorelin 10 mg vial
Over 99% Purity
Premium-quality research compound
Shipped from the Gold Coast, Queensland
Australia Post Express Post
Why Choose Tesamorelin 10 mg?
Tesamorelin is a modified 44-amino-acid analogue corresponding to the full sequence of human growth-hormone-releasing hormone.
Researchers investigate Tesamorelin in relation to:
GHRH-receptor activation
Pituitary somatotroph-cell activity
Growth-hormone secretion pathways
GH–IGF-1 axis signalling
Pulsatile endocrine activity
Lipid-metabolism pathways
Adipose-tissue signalling
Body-composition research
Its stabilised GHRH-based structure makes Tesamorelin an important compound for specialised endocrine, pituitary, metabolic, and receptor-signalling research.
Tesamorelin Research
Tesamorelin is commonly investigated in laboratory and clinical research relating to:
Growth-hormone-releasing hormone activity
GHRH-receptor binding and activation
Pituitary-cell signalling
Growth-hormone secretory responses
IGF-1-associated pathways
Somatotropic-axis activity
Visceral-adipose-tissue metabolism
Lipolytic signalling
Triglyceride-metabolism pathways
Glucose-regulation mechanisms
Liver-fat research
Body-composition changes
Research continues into how Tesamorelin influences pituitary signalling, endogenous growth-hormone release, IGF-1-associated activity, lipid metabolism, and adipose-tissue pathways.
Growth-Hormone-Releasing Hormone Analogue Research
Tesamorelin is a synthetic analogue of human GHRH (1–44) with an N-terminal modification designed to improve resistance to enzymatic degradation.
It is composed of the following 44-amino-acid sequence:
Tyr-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-Gln-Gln-Gly-Glu-Ser-Asn-Gln-Glu-Arg-Gly-Ala-Arg-Ala-Arg-Leu
Researchers investigate this specialised peptide for its potential to:
Bind to growth-hormone-releasing hormone receptors
Activate receptor-mediated pituitary signalling
Influence endogenous growth-hormone secretion
Affect GH–IGF-1 axis activity
Support research into lipid-metabolism pathways
Assist investigation of adipose-tissue signalling
Influence body-composition markers under controlled conditions
Available evidence includes laboratory and clinical research involving regulated pharmaceutical preparations. Results from those preparations cannot be assumed to apply to an independently supplied research compound.
Premium Research Compound. One Easy Order.
OZZ Peptides Tesamorelin 10 mg provides researchers with a convenient option for investigating GHRH-receptor activity, pituitary signalling, GH–IGF-1 pathways, lipid metabolism, and adipose-tissue biology.
Securely packed and shipped directly from the Gold Coast using Australia Post Express Post.
Product Highlights
🧬 GHRH-Analogue Research
A stabilised 44-amino-acid analogue of human growth-hormone-releasing hormone.
🔬 Pituitary-Signalling Research
Investigated for its interaction with GHRH receptors on pituitary somatotroph cells.
📈 GH–IGF-1 Axis Research
Studied in relation to endogenous growth-hormone secretion and IGF-1-associated signalling.
🧫 Adipose-Tissue Research
Used in controlled studies examining visceral-adipose-tissue and body-composition pathways.
⚡ Lipid-Metabolism Research
Investigated in relation to lipolysis, triglyceride metabolism, and cellular-energy regulation.
🔄 Endocrine-Pathway Research
Studied for its role in receptor-mediated and pulsatile endocrine signalling.
💎 Over 99% Purity
Premium-quality research compound.
📦 Fast Australian Delivery
Sent using Australia Post Express Post.
🌴 Gold Coast Based
Packed and shipped by the OZZ Peptides team in Queensland.
What You’ll Receive
1x Tesamorelin 10 mg vial
Securely packed for delivery
Australia Post Express Post
Storage
Store according to the storage information supplied with the product.
Before reconstitution, keep the vial in a cool, dry environment away from direct sunlight. After reconstitution, appropriate refrigerated storage may be required according to the supplier’s specifications and applicable laboratory protocol.
Important Information
Products supplied by OZZ Peptides are intended for laboratory research purposes only and are not intended for human consumption, injection, growth-hormone enhancement, fat loss, weight management, body-composition modification, performance enhancement, diagnosis, treatment, cure, or prevention of any disease.
This Tesamorelin research preparation has not been evaluated by the Australian Therapeutic Goods Administration for safety, quality, or effectiveness and is not supplied as an approved medicine.
Athlete warning: Growth-hormone-releasing factors and their analogues are prohibited under the World Anti-Doping Agency Prohibited List. Competitive athletes should not use or handle this product outside properly authorised research settings.

